Despite some harsh words describing Monsanto’s conduct, a federal judge said last week he plans to reduce an $80 million award to a California man who claimed exposure to Roundup caused his non-Hodgkin lymphoma.

Glyphosate registrants defended their products as safe to use in comments submitted this week to the Agency for Toxic Substances and Disease Registry, which issued a report in April saying it could not “rule out” an association between exposure to glyphosate-based products and the risk of cancer.

Glyphosate is one of 28 pesticide product lines that President Trump is threatening to hit with tariffs of up to 25% starting next month. The crop protection industry is asking for exclusions and warning that costs could rise for manufacturers and farmers.

An effort by the Environmental Working Group seeks to eliminate the use of glyphosate in oat production, but farm and food industry groups are defending growers’ use of the herbicide and accusing EWG of trying to scare consumers away from oat products without justification.

University of Tennessee researchers are advising farmers and pesticide applicators to avoid mixing Roundup with dicamba because of the possibility of volatilization.

Bayer is not backing down from its defense of glyphosate following a jury’s award of more than $2 billion to a California couple who allege their use of Roundup over about 30 years caused their non-Hodgkin’s lymphoma.

The Environmental Protection Agency has kicked off comment periods on two glyphosate-related matters — one a proposed interim registration decision and one a petition to eliminate its use as a pre-harvest dessicant for oats.

The Environmental Protection Agency says glyphosate is not “likely” a human carcinogen.